Clinical Trial Update: The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the potential neuroprotective effects of lamotrigine and interferon beta-1a in patients with relapsing-remitting multiple sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)
• Lamotrigine (lamotrigine)

Snippet

Sponsor: Cantonal Hospital of St. Gallen | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 2 | Status: UNKNOWN